Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18325-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#18325-1-AP, RRID:AB_10640673
- Product name
- PHD3 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PHD3 antibody (Cat. #18325-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways.
Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1α and pyruvate kinase M2.
Prolyl Hydroxylase 3 Attenuates MCL-1-Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells.
Overexpression of the HIF hydroxylase PHD3 is a favorable prognosticator for gastric cancer.
Chen T, Li K, Liu Z, Liu J, Wang Y, Sun R, Li Z, Qiu B, Zhang X, Ren G, Xu Y, Zhang Z
Molecular therapy : the journal of the American Society of Gene Therapy 2021 Jun 2;29(6):2134-2150
Molecular therapy : the journal of the American Society of Gene Therapy 2021 Jun 2;29(6):2134-2150
Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1α and pyruvate kinase M2.
Chu X, Xiang M, Feng L, Liu H, Zhou C
Journal of thoracic disease 2019 Sep;11(9):3941-3950
Journal of thoracic disease 2019 Sep;11(9):3941-3950
Prolyl Hydroxylase 3 Attenuates MCL-1-Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells.
Radhakrishnan P, Ruh N, Harnoss JM, Kiss J, Mollenhauer M, Scherr AL, Platzer LK, Schmidt T, Podar K, Opferman JT, Weitz J, Schulze-Bergkamen H, Koehler BC, Ulrich A, Schneider M
Cancer research 2016 Apr 15;76(8):2219-30
Cancer research 2016 Apr 15;76(8):2219-30
Overexpression of the HIF hydroxylase PHD3 is a favorable prognosticator for gastric cancer.
Su C, Huang K, Sun L, Yang D, Zheng H, Gao C, Tong J, Zhang Q
Medical oncology (Northwood, London, England) 2012 Dec;29(4):2710-5
Medical oncology (Northwood, London, England) 2012 Dec;29(4):2710-5
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HT-1080 cells were subjected to SDS PAGE followed by western blot with 18325-1-AP(EGLN3 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human brain using 18325-1-AP(EGLN3 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PHD3 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human PHD3. This antibody recognizes human antigen. The PHD3 antibody has been validated for the following applications: ELISA, WB, IHC analysis.